Semen Indonesia Allocates Entire 2025 Profit of Rp 190.85 Billion as Dividends

Corporate Secretary of PT Semen Indonesia (Persero) Tbk (SIG), Vita Mahreyni, stated that the company has allocated its entire 2025 book profit of Rp 190.85 billion as cash dividends. “The allocation of the entire 2025 book profit as cash dividends represents the company’s commitment to providing added value to shareholders,” Vita said in her statement on Saturday, 9 May 2026. The decision was approved at the Annual General Meeting of Shareholders (AGMS) for the 2025 book year, held on Friday, 8 May 2026. Vita noted that the company successfully navigated challenges, particularly in the second half of 2025, through the implementation of transformation strategies that created a positive performance trend. According to her, this positive trend continued into the first quarter of 2026, serving as a foundation for the company to maintain growth momentum. “Going forward, SIG is prepared to sustain this growth momentum to optimise sustainable positive performance and deliver added value to shareholders,” she stated. Vita added that the disciplined execution of business transformation has successfully enhanced the company’s competitiveness amid domestic industry challenges, while also strengthening its position in international markets. For information, in addition to approving the dividends, the AGMS also endorsed the company’s 2025 annual report and the appointment of a public accounting firm to audit the financial statements. The meeting further approved the accountability report on the realisation of funds from the limited public offering through capital increase with pre-emptive rights (PMHMETD I), as well as amendments to the company’s articles of association. The AGMS then authorised the largest Series B shareholder or their proxy to determine the remuneration for members of the Board of Commissioners and Board of Directors for the 2026 book year, along with performance-based remuneration for the 2025 book year in accordance with applicable provisions. Additionally, the AGMS agreed to grant authority to the Board of Commissioners, with written approval from the largest Series B shareholder, to approve the Company’s Long-Term Plan (RJPP) for 2026–2030 and the Work Plan and Company Budget (RKAP) for 2027, including any amendments thereto.